Evidence map›Paper›PMID 25989524›Full record

ArticleScientific reports2015

In vivo two-photon imaging of axonal dieback, blood flow, and calcium influx with methylprednisolone therapy after spinal cord injury.

Peifu Tang, Yiling Zhang, Chao Chen, Xinran Ji, Furong Ju, Xingyu Liu, Wen-Biao Gan, Zhigang He, Shengxiang Zhang, Wei Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Neural regeneration research · 2024
    Review
  10. Article
  11. CaNeural regeneration research · 2023
    Article
  12. Brain & spine · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. IPNeurobiology of disease · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Peifu TangDepartment of Orthopedics, the General Hospital of Chinese People's Liberation Army, Beijing, China, 100853.
Yiling Zhang1] Department of Orthopedics, the General Hospital of Chinese People's Liberation Army, Beijing, China, 100853 [2] Key Laboratory of Chemical Genomics, Shenzhen Graduate School, Peking University, Shenzhen, China, 518055.
Chao Chen1] Department of Orthopedics, the General Hospital of Chinese People's Liberation Army, Beijing, China, 100853 [2] Key Laboratory of Chemical Genomics, Shenzhen Graduate School, Peking University, Shenzhen, China, 518055.
Xinran JiDepartment of Orthopedics, the General Hospital of Chinese People's Liberation Army, Beijing, China, 100853.
Furong JuSchool of Life Sciences, Lanzhou University, Lanzhou, China, 73000.
Xingyu LiuBeijing YouAn Hospital, Capital Medical University, Beijing, China, 100069.
Wen-Biao Gan1] Key Laboratory of Chemical Genomics, Shenzhen Graduate School, Peking University, Shenzhen, China, 518055 [2] Skirball Institute, Department of Neuroscience and Physiology, New York University School of Medicine, New York, USA, 10016.
Zhigang HeF.M. Kirby Program in Neuroscience, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, USA, 02115.
Shengxiang ZhangSchool of Life Sciences, Lanzhou University, Lanzhou, China, 73000.
Wei LiKey Laboratory of Chemical Genomics, Shenzhen Graduate School, Peking University, Shenzhen, China, 518055.
Lihai ZhangDepartment of Orthopedics, the General Hospital of Chinese People's Liberation Army, Beijing, China, 100853.
People's Liberation Army No. 150 Hospital · CNLanzhou University · CNPeking University · CNBeijing YouAn Hospital · CNBoston Children's Hospital · USChinese People's Liberation Army · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe spinal cord injury (SCI) can cause neurological dysfunction and paralysis. However, the early dynamic changes of neurons and their surrounding environment after SCI are poorly understood. Although methylprednisolone (MP) is currently the standard therapeutic agent for treating SCI, its efficacy remains controversial. The purpose of this project was to investigate the early dynamic changes and MP's efficacy on axonal damage, blood flow, and calcium influx into axons in a mouse SCI model. YFP H-line and Thy1-GCaMP transgenic mice were used in this study. Two-photon microscopy was used for imaging of axonal dieback, blood flow, and calcium influx post-injury. We found that MP treatment attenuated progressive damage of axons, increased blood flow, and reduced calcium influx post-injury. Furthermore, microglia/macrophages accumulated in the lesion site after SCI and expressed the proinflammatory mediators iNOS, MCP-1 and IL-1β. MP treatment markedly inhibited the accumulation of microglia/macrophages and reduced the expression of the proinflammatory mediators. MP treatment also improved the recovery of behavioral function post-injury. These findings suggest that MP exerts a neuroprotective effect on SCI treatment by attenuating progressive damage of axons, increasing blood flow, reducing calcium influx, and inhibiting the accumulation of microglia/macrophages after SCI.

Indexed as

Microscopy, FluorescencePhotonsRegional Blood FlowAnimalsAxonsBehavior, AnimalCalciumCalpainCaspase 3Cell DeathDisease Models, AnimalGene Expression RegulationMacrophagesMethylprednisoloneMiceMicrocirculationCalciumCalpainCapn1 protein, mouseCaspase 3Methylprednisolone

Identifiers

PMID25989524
PMCPMC4437044
OpenAlexW2134530375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.